One of the primary benefits is that CARs are intended to identify antigens independently of MHC molecules, which are frequently downregulated in tumor cells as a mechanism of immune evasion.441 This advancement allows CAR-T cells to specifically target tumor cells that might evade recognition by conventional T cells. Here, HLA-C is linked to neoplasm.